3-Hydroxy-3-methylglutaric acid hydrogen 1-(2,3,15,19,23,27,31-heptahydroxy-3,7,11,15,19,23,27,31,35-nonamethyl-6,10,34-hexatriacontatrien-1-yl) ester (86702-30-9)

Other Product

• 1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
• 1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
• 1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
• 1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
• 1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
• 1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
• 1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
• 4,8,12,16,20,24,28-Heptaazahentriacontanoic acid,31-amino-15-(4-aminobutyl)-7-(hydroxymethyl)-31-(1H-imidazol-4-yl)-3-(mercaptomethyl)-27-methyl-18,23-bis(1-methylethyl)-11-(2-methylpropyl)-5,9,13,17,21,25,29-heptaoxo-,(3R,7S,11S,15S,18S,23R,27R,31R)-
• 4,8,12,16,20,24,28-Heptaazahentriacontanoic acid,31-amino-15-(4-aminobutyl)-7-(hydroxymethyl)-31-(1H-imidazol-4-yl)-3-(mercaptomethyl)-27-methyl-18,23-bis(1-methylethyl)-11-(2-methylpropyl)-5,9,13,17,21,25,29-heptaoxo-,(3R,7S,11S,15S,18S,23R,27R,31R)-, tr
• 4,8,12,16,20,24,28-Heptaazahentriacontanoic acid,31-amino-15-(4-aminobutyl)-7-(hydroxymethyl)-31-(1H-imidazol-4-yl)-3-(mercaptomethyl)-27-methyl-18,23-bis(1-methylethyl)-11-(2-methylpropyl)-5,9,13,17,21,25,29-heptaoxo-,(3R,7S,11S,15S,18S,23R,27R,31R)-, pe
• 1/C23H22N2O2/c26-23(27-22-15-25-11-7-17(22)8-12-25)21-14-18(13-16-5-9-24-10-6-16)19-3-1-2-4-20(19)21/h1-6,9-10,13-14,17,22H,7-8,11-12,15H2/b18-13
• Colony-stimulatingfactor 2 (human clone pHG25 protein moiety reduced), 23-L-leucine-27-L-asparticacid-39-L-glutamic acid-, (127®9')-protein with 9-glycine-10-glycine-11-glycine-12-glycine-13-L-serine-14-glycine-15-glycine-16-glycine-18-glycine-19-L-serine-34-L-asparticacid-89-L-aspartic acid-9-152-interleukin 3 (human clone D11 precursor proteinmoiety reduced)
• 1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
• 1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
• 1/C16H15FN2O3S/c1-23(21,22)19-14-5-3-2-4-13(14)18-16(20)10-15(19)11-6-8-12(17)9-7-11/h2-9,15H,10H2,1H3,(H,18,20
• 1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
• 1/C18H18O6/c1-22-14-8-13(20)15-16(21)11(9-24-18(15)17(14)23-2)7-10-3-5-12(19)6-4-10/h3-6,8,11,19-20H,7,9H2,1-2H
• 1/C17H22N6/c1-2-8-19-13-11-14(23-10-9-18-12-23)20-16-15(13)21-17(22-16)6-4-3-5-7-17/h9-12,19H,2-8H2,1H
• 1/C19H24N2O2/c1-12(2)14-8-6-9-15(13(3)4)17(14)21-19(22)18-16(23-5)10-7-11-20-18/h6-13H,1-5H3,(H,21,22
• Spiro[furan-2(3H),2'-[2H,21H]porphine],1',3',4',- 5',6',7',8',9',10',11',12',13',14',15',16',17',18',19',- 20',23'-eicosahydro-